Grupo Sura is a Colombian diversified insurer and financial group, writing life, health, auto, property and pension business across Colombia and its Latin American operations, and it earns most of its premium through the pension and savings side of the house as well as its general insurance book. The advantage here is scale in a concentrated market: a 22.1% operating margin and a 52.2% gross margin sit well above what a typical regional insurer produces, and the 11.0% ROE suggests the capital base is still large relative to earnings. Revenue growth of 18.1% is the most useful number in the data set, because it points to premium expansion rather than a reliance on investment income or a single product line. The stock trades at 10.7 times trailing earnings with no forward multiple available, which means the market is pricing the current earnings base rather than a consensus growth path, a gap that a deeper look should close before any view is formed. Worth checking: how much of the 18.1% growth is organic versus currency or acquisition driven, and whether the margin holds once the regional mix shifts. The score of 88 and absence of index membership tells you the quality screen is strong while the name remains outside the major benchmarks.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 20 Oct 2026, 02:20 CEST | ACCE price target | COP 75000 | first publication | COP 70000 |
Answered from Grupo Sura ordinary fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| GRUPOSURA.CL Grupo Sura ordinary | COP 70420.00 | - | - | 10.9x | 11.0% | 67 | 88 |
| ICICIGI.NS ICICI Lombard General Insurance Company Limited | ₹1592.00 | - | - | 31.3x | 13.6% | 68 | 57 |
| PFGRUPSURA.CL Grupo Sura preferred | COP 59440.00 | - | - | 9.2x | 11.0% | 67 | 88 |
| BNT Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited Voting Shares | $37.95 | - | - | 45.2x | 1.1% | 39 | 41 |
| ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F | $18.07 | - | - | 3.8x | 19.9% | 87 | 44 |
| AEG Aegon Ltd. New York Registry Shares | $8.10 | $13 | 36% below | 11.7x | 11.1% | 59 | 51 |
| AGN.AS Aegon Ltd. | €7.31 | €11 | 34% below | 12.4x | 11.1% | 59 | 54 |
Where GRUPOSURA.CL ranks against its sector peers on each metric.